RxDoctor Payments Data

Rehan Ali, MD

Interventional Pain Medicine · Ridgewood, NJNPI 1144527011

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,847 of the $5,708 with a category attached, or 67.4%. 15 manufacturers reported payments, led by Medtronic at 42.1% of the total. Reporting peaked in 2019 at $2,712 and has fallen 82.7% since, to $469 in 2025.

$5,708in general payments, 2019–2025

Across 164 payments — averaging $34.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Vertos Medical, Inc.$900
  • Biotronik NRO, Inc.$826
  • Boston Scientific$756
  • Abbott$292
  • Nevro Corp.$182
  • plus $347 from 9 others

What the payments were for

  • Travel & lodging$1,86133%
  • Food & beverage$3,84767%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,708 in reported general payments places this provider in the 65th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$52,665
Medicare patients
72
Services billed
503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$272
Pregabalin11$173
Oxycodone Hcl13$135
Tramadol Hcl24$128
Cyclobenzaprine Hcl17$118
Gabapentin16$65

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Ridgewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →